VetMedGuide

Vet Med Guide

Pharmaceuticals2026-05-14 · 9 min read

FeLV Vaccine for Cats: Testing Before Vaccination and Adult Risk Decisions

Guideline-based guide to the FeLV vaccine: who needs it, why testing comes first, how risk categories change revaccination, and when adult cats can stop receiving it.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Feline leukemia virus (FeLV) is a retrovirus that suppresses the immune system, causes progressive bone marrow disease, and remains one of the leading infectious causes of death in cats. A vaccine exists, but the decision to use it is not automatic for every cat — it depends on age, lifestyle, test results, and ongoing exposure risk.

This article walks through the current guideline recommendations for FeLV vaccination, why testing before vaccination is non-negotiable, how the AAHA/AAFP framework stratifies risk, and what the evidence says about adult revaccination decisions.

Quick answer

Per the 2020 AAHA/AAFP Feline Vaccination Guidelines — still the U.S. reference standard in 2026 — FeLV vaccine is a core vaccine for all kittens and cats under 1 year of age. It becomes a non-core (risk-based) vaccine for adult cats over 1 year, recommended only for cats with realistic exposure to FeLV-positive cats or cats of unknown status.

All cats should be tested for FeLV antigen status before the first vaccination, regardless of age. Vaccinating an already-infected cat provides no therapeutic benefit and can create a false sense of security.

Two doses are given 3–4 weeks apart, starting at 8 weeks of age. A booster is given 12 months after the last dose in the initial series. After that, the revaccination interval depends on the cat's risk profile.

What FeLV is and why it matters

FeLV is transmitted through close contact: mutual grooming, shared food bowls, bite wounds, and from an infected queen to her kittens. The virus replicates in lymphoid tissue and bone marrow. In progressive infection — the most serious outcome — the cat remains persistently viremic, sheds virus continuously, and develops fatal disease within months to a few years.

Not every exposed cat develops progressive infection. The immune response in many adult cats can contain or eliminate the virus. This age-related resistance is a key reason the guidelines treat kittens differently from mature adults: kittens under 16 weeks are far more likely to become persistently infected after exposure.

Cornell University's Feline Health Center estimates that approximately 2–3% of healthy cats in the United States are FeLV-positive, with higher rates in sick cats, outdoor cats, and strays.

Why testing comes before vaccination

The AAFP and the Merck Veterinary Manual both recommend FeLV testing in the following situations:

  • All kittens at their first veterinary visit
  • All cats prior to entering a household with existing FeLV-negative cats
  • All cats in an existing household before a new cat is introduced
  • All cats prior to their first FeLV vaccination

Testing matters because FeLV vaccination will not help an already-infected cat. The AAFP's retrovirus management guidelines are explicit: vaccination should not be used as a substitute for testing and segregation.

What tests are available

The standard screening test at most veterinary clinics is a point-of-care ELISA or lateral-flow immunoassay that detects free FeLV p27 antigen in blood. This is the test typically run alongside FIV antibody screening at kitten visits.

  • Negative ELISA in a low-risk cat: generally reliable. Retest if the cat had a known exposure within the past 30 days, because early infection may not yet be detectable.
  • Positive ELISA: should be confirmed with a second method before making irreversible decisions. Confirmatory options include IFA (immunofluorescent antibody assay, which detects intracellular p27 in white blood cells and platelets), PCR for proviral DNA, or a second point-of-care test from a different manufacturer.

The ABCD (Advisory Board on Cat Diseases) guidelines note that false-positive ELISA results are more likely in populations with low FeLV prevalence. This is a mathematical reality of screening tests: when the disease is rare, even a test with 99% specificity produces proportionally more false positives than true positives.

Understanding progressive, regressive, and abortive infection

FeLV infection outcomes are not binary:

  • Progressive infection: The cat remains antigen-positive, sheds virus, and is at high risk for FeLV-related disease. Both ELISA and IFA remain positive on retesting weeks to months later.
  • Regressive infection: The immune system contains viral replication. The cat becomes antigen-negative on ELISA but retains proviral DNA detectable by PCR. These cats do not shed virus in saliva and are not infectious to other cats under normal conditions. However, the provirus persists for life and can reactivate under severe immunosuppression.
  • Abortive infection: The immune response eliminates the virus before integration. The cat tests negative on all assays and is immune.

This spectrum is why a single positive test should never be the sole basis for euthanasia or irreversible management decisions. Retesting at intervals, ideally with confirmatory methodology, is essential.

The FeLV vaccination schedule

The 2020 AAHA/AAFP Feline Vaccination Guidelines and the AAFP Feline Vaccination Advisory Panel recommend:

Step Timing Notes
First dose As early as 8 weeks of age After a negative FeLV test
Second dose 3–4 weeks after the first Completes the initial series
Booster at 1 year 12 months after the last dose in the series This is the third immunizing event
Adult revaccination Risk-based (see below) Interval depends on exposure level

Both recombinant (non-adjuvanted) and inactivated FeLV vaccines are available. The Task Force acknowledged conflicting evidence regarding comparative efficacy and safety between the two types. For injection-site sarcoma tracking, the AAHA/AAFP guidelines recommend giving parenteral FeLV vaccines subcutaneously in the left pelvic limb as distally as possible.

UC Davis's vaccination guidance notes that vaccination is most useful in kittens and young adults because acquired resistance to infection develops beyond 16 weeks of age. However, older cats can still become infected with sufficient exposure.

Adult risk stratification: when to continue and when to stop

After the 1-year booster, FeLV vaccination transitions from core to risk-based. The AAFP Advisory Panel categorizes adult revaccination by exposure level:

High-risk cats — revaccinate annually

  • Cats with outdoor access
  • Cats living with a known FeLV-positive cat
  • Cats in contact with cats of unknown FeLV status (multi-cat households, foster situations, group housing)

Low-to-moderate-risk cats — revaccinate every 2–3 years

  • Cats with limited outdoor access and low probability of contact with unknown-status cats
  • Cats in stable multi-cat households where all members are known FeLV-negative
  • Where product licensure allows extended DOI (duration of immunity), a 2–3 year interval may be used

No-risk cats — do not revaccinate

  • Single-cat household with no exposure to other cats
  • Indoor-only cats in a household where all cats are known FeLV-negative
  • Cats with no outdoor access (full enclosure does not count as outdoor exposure)

This last category is where many routine veterinary visits diverge from guideline recommendations. An indoor-only cat in a single-cat household, confirmed FeLV-negative, does not need ongoing FeLV vaccination according to the AAFP. However, if the cat's lifestyle could change — a new cat is introduced, the cat begins going outside — vaccination status should be reassessed.

Efficacy limitations

No FeLV vaccine is 100% effective at preventing infection in every vaccinated cat. The AAFP retrovirus management guidelines state this plainly: vaccination should never replace a test-and-segregate program in multi-cat environments.

Because sufficient protection is not induced in all vaccinated individuals, even vaccinated cats should not be housed with FeLV-positive cats if it can be avoided. Cornell's Feline Health Center and UC Davis both recommend against introducing FeLV-positive cats into households with FeLV-negative cats, even if the negative cats are vaccinated.

What the FeLV vaccine does not do

  • It does not treat existing FeLV infection. Vaccinating an FeLV-positive cat has no therapeutic value.
  • It does not produce positive test results on FeLV antigen tests. (This is different from the FIV vaccine, which can cause false-positive FIV antibody tests.)
  • It does not eliminate the need for testing in multi-cat management or before introduction of a new cat.

Vaccine safety and adverse effects

FeLV vaccines, like all vaccines, can cause adverse reactions. Common and typically mild effects include:

  • Lethargy or reduced appetite for 24–48 hours
  • Mild swelling at the injection site

Less common but more serious risks include:

  • Injection-site sarcomas (fibrosarcomas). This risk exists for all injectable feline vaccines and is not unique to FeLV products. The AAHA/AAFP guidelines recommend administering FeLV vaccines in the left pelvic limb distally to facilitate monitoring and, if necessary, wide excision.
  • Allergic or anaphylactic reactions (rare)

Cats with retroviral infections (FeLV or FIV) can still receive core vaccines — the AAFP retrovirus guidelines advise against avoiding vaccination in retrovirus-positive cats because they may develop more severe disease from natural exposure than from vaccination.

What to ask your veterinarian

If your cat is due for an FeLV vaccine decision, these questions help frame the conversation:

  1. Has my cat been tested for FeLV? If not, testing should happen before vaccination.
  2. What is my cat's actual exposure risk? Indoor-only in a single-cat household is different from a cat that goes outside or lives with cats of unknown status.
  3. Does my adult cat still need this vaccine? For many strictly indoor, single-cat adults in FeLV-negative households, the answer based on AAFP guidelines is no.
  4. If my kitten just completed the series, when is the next booster due? The 1-year booster is important — it should not be skipped.
  5. Which vaccine type is being used? Recombinant (non-adjuvanted) products may have a different risk profile for injection-site reactions.

Sources

Topics
Vaccination & Infectious Disease
Related Articles